Chemotherapy-Induced Alopecia in Ovarian Cancer: Incidence, Mechanisms, and Impact Across Treatment Regimens

    January 2025 in “ Cancers
    Simonetta I. Gaumond, Gabriela E Beraja, Isabella Kamholtz, Lina M. Ferrari, Rami H. Mahmoud, Joaquín J. Jiménez
    TLDR Improving treatment plans can reduce hair loss and improve life quality for ovarian cancer patients.
    Chemotherapy-induced alopecia (CIA) significantly affects the psychosocial well-being of ovarian cancer patients. The document emphasizes the importance of optimizing treatment protocols to minimize the severity of alopecia while maintaining the effectiveness of cancer therapy. The insights provided could inform future therapeutic strategies aimed at enhancing patient outcomes and quality of life.
    Discuss this study in the Community →

    Research cited in this study

    10 / 10 results

    Related Community Posts Join

    6 / 66 results

    Similar Research

    5 / 1000+ results
      Mucocutaneous Reactions to Chemotherapy

      research Mucocutaneous Reactions to Chemotherapy

      275 citations , March 1999 in “Journal of The American Academy of Dermatology”
      Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.
      Hair Disorders in Patients with Cancer

      research Hair Disorders in Patients with Cancer

      53 citations , April 2018 in “Journal of The American Academy of Dermatology”
      Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.
      Alopecia in Association with Malignancy: A Review

      research Alopecia in Association with Malignancy: A Review

      26 citations , August 2018 in “American Journal of Clinical Dermatology”
      Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.